Antogen

Antogen is a private life science tools, diagnostics, and contract research company focused on immune surveillance, HLA testing, and immunopeptidomics. The company provides services to identify and quantify peptide-HLA ligands directly from biological samples, supporting therapeutic discovery, translational research, biomarker development, and clinical research. Antogen is also developing a broader next-generation immune surveillance platform that combines proteomics, machine learning models, and proprietary biological datasets. Its work is positioned at the intersection of precision medicine, oncology, immunotherapy, and autoimmune disease research, and the company has reported early commercial traction through contract research services.